Cetuximab plus FOLFOXIRI versus cetuximab plus FOLFOX as con

Cetuximab plus FOLFOXIRI versus cetuximab plus FOLFOX as conversion regimen in RAS/BRAF wild-type patients with initially unresectable colorectal liver metastases (TRICE trial): A randomized controlled trial

Cetuximab plus FOLFOXIRI versus cetuximab plus FOLFOX as conversion regimen in RAS/BRAF wild-type patients with initially unresectable colorectal liver metastases (TRICE trial): A randomized controlled trial

plos.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from plos.org Daily Mail and Mail on Sunday newspapers.

Related Keywords

Cairo , Al Qahirah , Egypt , South Korea , China , United States , Cancer Institute , Guangdong , Jilin , Helsinki , Eteläuomen Läi , Finland , Japan , Ramit Singal , World Medical Association , Eastern Cooperative Oncology Group , Sun Yat Sen University , National Cancer Institute , Research Foundation Grant , Sun Yat Sen University Cancer Center , National Natural Science Foundation Of China Grant , Sun Yat Sen University Deposit , University Of Texas Southwestern Medical Center , Wangd S , Texas Southwestern Medical Center , Creative Commons Attribution License , Sun Yat Sen , National Natural Science Foundation , Guangdong Basic , Applied Basic Research Foundation , Interactive Web Response System , World Medical , Human Research Ethics Committee , Clinical Trial Number , Common Terminology Criteria , Adverse Events , Graphpad Prism ,